Wendi L Kuhnert
Overview
Explore the profile of Wendi L Kuhnert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
1216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Honein M, Christie A, Rose D, Brooks J, Meaney-Delman D, Cohn A, et al.
MMWR Morb Mortal Wkly Rep
. 2020 Dec;
69(49):1860-1867.
PMID: 33301434
In the 10 months since the first confirmed case of coronavirus disease 2019 (COVID-19) was reported in the United States on January 20, 2020 (1), approximately 13.8 million cases and...
2.
Jamieson D, Skunodom N, Chaowanachan T, Roongpisuthipong A, Bower W, Chotpitayasunondh T, et al.
Infect Dis Obstet Gynecol
. 2009 Feb;
2008:840948.
PMID: 19190779
Objective: The purpose of this study was to describe the epidemiology of coinfection with hepatitis C virus (HCV) and HIV among a cohort of pregnant Thai women. Methods: Samples from...
3.
Perz J, Elm Jr J, Fiore A, Huggler J, Kuhnert W, Effler P
Pediatrics
. 2006 Oct;
118(4):1403-8.
PMID: 17015529
Objectives: Hawaii implemented routine infant hepatitis B vaccination in 1992 and required it for school entry in 1997. Previously, in 1989, a serologic survey among Hawaii school children in grades...
4.
Bower W, Culver D, Castor D, Wu Y, James V, Zheng H, et al.
J Acquir Immune Defic Syndr
. 2006 Jun;
42(3):293-7.
PMID: 16763522
Background: Reports are mixed as to whether highly active antiretroviral therapy (HAART) increases liver transaminase levels or hepatitis C virus (HCV) titers in HIV/HCV-coinfected individuals. It is hypothesized that increases...
5.
Armstrong G, Wasley A, Simard E, McQuillan G, Kuhnert W, Alter M
Ann Intern Med
. 2006 May;
144(10):705-14.
PMID: 16702586
Background: Defining the primary characteristics of persons infected with hepatitis C virus (HCV) enables physicians to more easily identify persons who are most likely to benefit from testing for the...
6.
Armstrong G, Williams I, Maga U, Viali S, Kuhnert W, McGarvey S
Am J Trop Med Hyg
. 2006 Feb;
74(2):261-2.
PMID: 16474081
Little is known about the prevalence of hepatitis C virus (HCV) in Pacific islands. In this study, serum specimens collected in 1985 and 2002 among the general populations of Samoa...
7.
Kuhnert W, Zheng G, Faustoferri R, Quivey Jr R
J Bacteriol
. 2004 Dec;
186(24):8524-8.
PMID: 15576803
Streptococcus mutans F-ATPase, the major component of the acid-adaptive response of the organism, is transcriptionally upregulated at low pH. Fusions of the F-ATPase promoter to chloramphenicol acetyltransferase indicated that pH-dependent...
8.
Kuhnert W, Quivey Jr R
J Bacteriol
. 2003 Feb;
185(5):1525-33.
PMID: 12591869
Oral streptococci utilize an F-ATPase to regulate cytoplasmic pH. Previous studies have shown that this enzyme is a principal determinant of aciduricity in the oral streptococcal species Streptococcus sanguis and...
9.
Alter M, Kuhnert W, Finelli L
MMWR Recomm Rep
. 2003 Feb;
52(RR-3):1-13, 15; quiz CE1-4.
PMID: 12585742
Testing for the presence of antibody to hepatitis C virus (anti-HCV) is recommended for initially identifying persons with hepatitis C virus (HCV) infection (CDC. Recommendations for prevention and control of...